AURKA and cancer: In NSCLC, overexpression of AURKA was regarded as a poor prognosis and therefore AURKA inhibitors could not only cause G2/M arrest of cancer cells but also lead to the significant autophagy and enhance the anticancer activity of clinical medicine (Katayama and sen., 2010).